Regeneron opposes Amgen's motion for judgment in US antitrust case
MLex Summary: Amgen’s request for judgment as a matter of law rehashes the same arguments it presented to the jury and ignores the record as if the trial never happened, Regeneron...To view the full article, register now.
Already a subscriber? Click here to view full article